Berkeley Lights and MD Anderson launch cell therapy JV
Berkeley Lights and MD Anderson Cancer Centre have created a company aimed at developing autologous cell therapies to treat solid tumours.
Archives for March 9, 2018
First Herceptin biosimilar launched in UK
Merck & Co. will take on Roche as Ontruzant becomes the first biosimilar of cancer drug Herceptin (trastuzumab) to be launched in Europe.
AGC Biologics adds 2,000L single-use bioreactor in CA
The biologics CDMO will install a 2,000L single-use bioreactor (SUB) from Thermo Fisher Scientific at its Berkeley facility to meet demand for early-phase projects.